Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2018 Filed Feb 21, 2018 01:00 UTC |
McLaughlin Mark10% owner
|
Disposition to issuerCommon Stock, par value $0.01 | 217,391 | $0.23 | $49,999.93 |
DisclosureSEC source: 0001213900-18-002139 · f4021318mclaughlin_immudyne.xml · nonDerivative · entry 7 McLaughlin Mark · CIK 0001721526 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · James McLaughlin - Son Disclosed balance after: 553,284 F1 · price: As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share. F1 · ownership.nature: As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share. F2 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 13, 2018 Filed Feb 21, 2018 01:00 UTC |
McLaughlin Mark10% owner
|
SaleCommon Stock, par value $0.01 | 5,504 | $0.23 | $1,265.92 |
DisclosureSEC source: 0001213900-18-002139 · f4021318mclaughlin_immudyne.xml · nonDerivative · entry 6 McLaughlin Mark · CIK 0001721526 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Genevieve McLaughlin - Daughter Disclosed balance after: 506,780 F2 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. F5 · ownership.nature: These shares were sold in private transactions in connection with the transactions contemplated by the Legacy Assets Sale Agreement. Read SEC document |
| February 13, 2018 Filed Feb 21, 2018 01:00 UTC |
McLaughlin Mark10% owner
|
Disposition to issuerCommon Stock, par value $0.01 | 217,391 | $0.23 | $49,999.93 |
DisclosureSEC source: 0001213900-18-002139 · f4021318mclaughlin_immudyne.xml · nonDerivative · entry 5 McLaughlin Mark · CIK 0001721526 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Genevieve McLaughlin - Daughter Disclosed balance after: 512,284 F1 · price: As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share. F1 · ownership.nature: As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share. F2 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 13, 2018 Filed Feb 21, 2018 01:00 UTC |
McLaughlin Mark10% owner
|
SaleCommon Stock, par value $0.01 | 190,000 | $0.23 | $43,700.00 |
DisclosureSEC source: 0001213900-18-002139 · f4021318mclaughlin_immudyne.xml · nonDerivative · entry 4 McLaughlin Mark · CIK 0001721526 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Bruni McLaughlin - Spouse Disclosed balance after: 54,228 F2 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. F4 · ownership.nature: These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement. Read SEC document |
| February 13, 2018 Filed Feb 21, 2018 01:00 UTC |
McLaughlin Mark10% owner
|
SaleCommon Stock, par value $0.01 | 100,000 | $0.23 | $23,000.00 |
DisclosureSEC source: 0001213900-18-002139 · f4021318mclaughlin_immudyne.xml · nonDerivative · entry 3 McLaughlin Mark · CIK 0001721526 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · McLaughlin International, Inc. Disclosed balance after: 1,040,000 F3 · ownership.nature: The Reporting Persons beneficially owns shares through a company owned together with his spouse. Read SEC document |
| February 13, 2018 Filed Feb 21, 2018 01:00 UTC |
McLaughlin Mark10% owner
|
SaleCommon Stock, par value $0.01 | 298,407 | $0.23 | $68,633.61 |
DisclosureSEC source: 0001213900-18-002139 · f4021318mclaughlin_immudyne.xml · nonDerivative · entry 2 McLaughlin Mark · CIK 0001721526 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,342,100 F4 · ownership.direct: These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement. Read SEC document |
| February 13, 2018 Filed Feb 21, 2018 01:00 UTC |
McLaughlin Mark10% owner
|
Disposition to issuerCommon Stock, par value $0.01 | 1,130,436 | $0.23 | $260,000.28 |
DisclosureSEC source: 0001213900-18-002139 · f4021318mclaughlin_immudyne.xml · nonDerivative · entry 1 McLaughlin Mark · CIK 0001721526 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,640,507 F1 · ownership.direct: As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 23:01 UTC |
Schreiber JustinDirector · President, Immudyne PR · 10% owner
|
PurchaseCommon Stock, par value $0.01 | 600,000 | $0.23 | $138,000.00 |
DisclosureSEC source: 0001720512-18-000001 · primary_doc.xml · nonDerivative · entry 1 Schreiber Justin · CIK 0001720512 · Director · President, Immudyne PR · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · JOJ Holdings, LLC Disclosed balance after: 2,618,693 Read SEC document |
| December 05, 2017 Filed Dec 6, 2017 14:34 UTC |
Schreiber JustinDirector · President, Immudyne PR · 10% owner
|
PurchaseCommon Stock, par value $0.01 | 25,133 | $0.39 | $9,801.87 |
DisclosureSEC source: 0001720512-17-000003 · primary_doc.xml · nonDerivative · entry 1 Schreiber Justin · CIK 0001720512 · Director · President, Immudyne PR · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · JOJ Holdings, LLC Disclosed balance after: 2,018,693 Read SEC document |
| December 04, 2017 Filed Dec 5, 2017 21:51 UTC |
Schreiber JustinDirector · President, Immudyne PR · 10% owner
|
PurchaseCommon Stock, par value $0.01 | 24,867 | $0.39 | $9,698.13 |
DisclosureSEC source: 0001720512-17-000002 · primary_doc.xml · nonDerivative · entry 1 Schreiber Justin · CIK 0001720512 · Director · President, Immudyne PR · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · JOJ Holdings, LLC Disclosed balance after: 1,993,560 Read SEC document |
| November 03, 2017 Filed Nov 3, 2017 19:31 UTC |
Schreiber JustinDirector · President, Immudyne PR · 10% owner
|
OtherWarrant · Derivative | 67,861 | $0.40 Strike: $0.40 | $27,144.40 |
DisclosureSEC source: 0001720512-17-000001 · primary_doc.xml · derivative · entry 4 Schreiber Justin · CIK 0001720512 · Director · President, Immudyne PR · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · JOJ Holdings, LLC Disclosed balance after: 67,861 Underlying: Common Stock, par value $0.01 · 67,861 shares Expires 2019-11-03 F1 · kind: Reporting person converted capital contributions to Immudyne PR, LLC pursuant to a subscription agreement. $31,215.94 was converted at $0.23 cents into 135,721 shares and 50% warrant coverage at $0.40. Read SEC document |
| November 03, 2017 Filed Nov 3, 2017 19:31 UTC |
Schreiber JustinDirector · President, Immudyne PR · 10% owner
|
OtherCommon Stock, par value $0.01 | 135,721 | $0.23 | $31,215.83 |
DisclosureSEC source: 0001720512-17-000001 · primary_doc.xml · nonDerivative · entry 2 Schreiber Justin · CIK 0001720512 · Director · President, Immudyne PR · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · JOJ Holdings, LLC Disclosed balance after: 1,968,693 F1 · kind: Reporting person converted capital contributions to Immudyne PR, LLC pursuant to a subscription agreement. $31,215.94 was converted at $0.23 cents into 135,721 shares and 50% warrant coverage at $0.40. Read SEC document |
| October 26, 2017 Filed Nov 3, 2017 19:31 UTC |
Schreiber JustinDirector · President, Immudyne PR · 10% owner
|
PurchaseCommon Stock, par value $0.01 | 2,700 | $0.41 | $1,119.15 |
DisclosureSEC source: 0001720512-17-000001 · primary_doc.xml · nonDerivative · entry 1 Schreiber Justin · CIK 0001720512 · Director · President, Immudyne PR · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · JOJ Holdings, LLC Disclosed balance after: 1,832,972 Read SEC document |
| October 19, 2017 Filed Oct 27, 2017 21:49 UTC |
Schreiber JustinDirector · President, Immudyne PR · 10% owner
|
PurchaseCommon Stock, par value $0.01 | 25,000 | $0.42 | $10,495.00 |
DisclosureSEC source: 0001213900-17-011046 · f4101917schreiber_immudyne.xml · nonDerivative · entry 1 Schreiber Justin · CIK 0001720512 · Director · President, Immudyne PR · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · JOJ Holdings, LLC Disclosed balance after: 1,830,272 Read SEC document |
| October 01, 2017 Filed Mar 4, 2019 11:03 UTC |
Kalkstein Robert LChief Financial Officer
|
OtherOptions to purchase Common Stock · Derivative | 150,000 | $0.28 Strike: $0.28 | $42,000.00 |
DisclosureSEC source: 0001213900-19-003447 · ownership.xml · derivative · entry 1 Kalkstein Robert L · CIK 0001526136 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2027-09-30 F1 · kind: These options were previously reported by Mr. Kalkstein on his Form 3 filed with the Commission on November 13, 2017. Pursuant to an amendment to his consulting agreement with Conversion Labs, Inc., the exercise price of these options were reduced from $0.40 to $0.28. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.